The European spallation source (ESS) will be the world’s brightest neutron source and will open a new intensity frontier in particle physics. The HIBEAM collaboration aims to exploit the unique potential of the ESS with a dedicated ESS instrument for particle physics which offers world-leading capability in a number of areas. The HIBEAM program includes the first search in thirty years for free neutrons converting to antineutrons and searches for sterile neutrons, ultralight axion dark matter and nonzero neutron electric charge. This paper outlines the capabilities, design, infrastructure, and scientific potential of the HIBEAM program, including its dedicated beamline, neutron optical system, magnetic shielding and control, and detectors for neutrons and antineutrons. Additionally, we discuss the long-term scientific exploitation of HIBEAM, which may include measurements of the neutron electric dipole moment and precision studies of neutron decays.
This article presents a cost optimisation study of neutron scattering instrumentation at the European Spallation Source (ESS) in Lund, Sweden. This is done by focusing on the main cost drivers for almost half of the instrument hardware—optics and shielding —and trading detailed cost functions against beam transmission functions in a multi-dimensional, yet simple, parameter space. A cost saving of almost 30% is identified. The method is demonstrated in a worked example on a mature instrument design, and there are no reductions in performance. The proposed solution is shown to correspond to a Nash equilibrium of simultaneous shielding and optics strategies, versus the baseline which is trapped by working through sequential strategies. Finally, this cost analysis is bench-marked against, and found to be in agreement with, the costs of operational facilities of a similar class.
The SARS-CoV-2 pandemic has created a demand for large scale testing, as part of the effort to understand and control transmission. It is important to quantify the error rates of test equipment under field conditions, which might differ significantly from those obtained in the laboratory. A literature review on SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) is used to construct a clinical test confusion matrix. A simple correction method for bulk test results is then demonstrated with examples. The required sensitivity and specificity of a test are explored for societal needs and use cases, before a sequential analysis of common example scenarios is explored. The analysis suggests that many of the people with mild symptoms and positive test results are unlikely to be infected with SARS-CoV-2 in some regions. It is concluded that current and foreseen alternative tests can not be used to “clear” people as being non-infected. Recommendations are given that regional authorities must establish a programme to monitor operational test characteristics before launching large scale testing; and that large scale testing for tracing infection networks in some regions is not viable, but may be possible in a focused way that does not exceed the working capacity of the laboratories staffed by competent experts. RT-PCR tests can not be solely relied upon as the gold standard for SARS-CoV-2 diagnosis at scale, instead clinical assessment supported by a range of expert diagnostic tests should be used.
The invention of self-shielding copper substrate neutron guides is described, along with the rationale behind the development, and the realisation of commercial supply. The relative advantages with respect to existing technologies are quantified. These include ease of manufacture, long lifetime, increased thermal conductivity, and enhanced fast neutron attenuation in the keV-MeV energy range. Whilst the activation of copper is initially higher than for other material options, for the full energy spectrum, many of the isotopes are short-lived, so that for realistic maintenance access times the radiation dose to workers is expected to be lower than steel and in the lowest zoning category for radiation safety outside the spallation target monolith. There is no impact on neutron reflectivity performance relative to established alternatives, and the manufacturing cost is similar to other polished metal substrates.
A literature review on SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) is used to construct a clinical test confusion matrix. A simple correction method for bulk test results is then demonstrated with examples. The required sensitivity and specificity of a test are explored for societal needs and use cases, before a sequential analysis of common example scenarios is explored. The analysis suggests that many of the people with mild symptoms and positive test results are unlikely to be infected with SARS-CoV-2 in some regions. It is concluded that current and foreseen alternative tests can not be used to “clear” people as being non-infected. Recommendations are given that regional authorities must establish a programme to monitor operational test characteristics before launching large scale testing; and that large scale testing for tracing infection networks in some regions is not viable, but may be possible in a focused way that does not exceed the working capacity of the laboratories staffed by competent experts. RT-PCR tests can not be solely relied upon as the gold standard for SARS-CoV-2 diagnosis at scale, instead clinical assessment supported by a range of expert diagnostic tests should be used.